A petition filed Oct. 24 alleges that magnesium from Israel is being sold at less than fair value in the U.S. market and benefitting from countervailable subsidies. The alleged average dumping margins range from 126.5 percent to 172.0 percent and there are 12 alleged countervailable subsidies.
The products covered by this petition are primary and secondary pure and alloy magnesium metal, regardless of chemistry, raw material source, form, shape, or size. Subject magnesium includes blends of primary magnesium, scrap, and secondary magnesium. Also included are the following pure and alloy magnesium metal products made from primary and/or secondary magnesium, including magnesium cast into ingots, slabs, t-bars, rounds, sows, billets, and other shapes and magnesium ground, chipped, crushed, or machined into raspings, granules, turnings, chips, powder, briquettes, and other shapes: (1) products that contain at least 99.95 percent magnesium, by weight; (2) products that contain less than 99.95 percent but not less than 99.8 percent magnesium, by weight; and (3) chemical combinations of magnesium and other material(s) in which the magnesium content is 50 percent or greater but less than 99.8 percent by weight, whether or not conforming to an ASTM specification for magnesium alloy.
Subject goods are classifiable under HTSUS 8104.11.00, 8104.19.00, and 8104.30.00.
The petition excludes (1) magnesium in liquid or molten form and (2) mixtures containing 90 percent or less magnesium in granular or powder form by weight and one or more of certain non-magnesium granular materials to make magnesium-based reagent mixtures, including lime, calcium metal, calcium silicon, calcium carbide, calcium carbonate, carbon, slag coagulants, fluorspar, nephaline syenite, feldspar, alumina, calcium aluminate, soda ash, hydrocarbons, graphite, coke, silicon, rare earth metals/mischmetal, cryolite, silica/fly ash, magnesium oxide, periclase, ferroalloys, dolomite lime, and colemanite.
The Department of Commerce and the International Trade Commission will next determine whether to launch AD and CV duty and injury investigations, respectively, on this product. There are strict statutory deadlines associated with these proceedings, so affected companies that wish to protect their interests should contact trade counsel as soon as possible.
For more information contact Kristen Smith at (202) 730-4965 or David Craven at (312) 279-2844.